Volitionrx (VNRX) Accumulated Expenses (2018 - 2025)

Volitionrx (VNRX) has 8 years of Accumulated Expenses data on file, last reported at $4.2 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Expenses rose 21.14% year-over-year to $4.2 million; the trailing twelve-month figure through Dec 2025 stood at $4.2 million (up 21.14% YoY), and the FY2025 full-year result was $4.2 million, up 21.14% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $4.2 million, down from $4.6 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $4.6 million in Q3 2025 and bottomed at $2.7 million in Q1 2023.
• The 5-year median for Accumulated Expenses is $3.5 million (2024), against an average of $3.5 million.
• The widest annual swing landed in 2022, when Accumulated Expenses declined 24.98%; it then soared 36.78% in 2023.
• A 5-year view of Accumulated Expenses shows it stood at $3.8 million in 2021, then declined by 24.98% to $2.9 million in 2022, then soared by 36.78% to $3.9 million in 2023, then slipped by 11.5% to $3.5 million in 2024, then increased by 21.14% to $4.2 million in 2025.
• The last three Accumulated Expenses figures came in at $4.2 million (Q4 2025), $4.6 million (Q3 2025), and $4.4 million (Q2 2025), per Business Quant data.

Peer Comparison